Peter M Rothwell Selected Research

danaparoid (Orgaran)

1/2020	Etiological Subtypes of Transient Ischemic Attack and Ischemic Stroke in Chronic Kidney Disease: Population-Based Study.
1/2019	Prognostic value of "tissue-based" definitions of TIA and minor stroke: Population-based study.
1/2018	Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.
1/2018	Time course of blood pressure control prior to lacunar TIA and stroke: Population-based study.
1/2017	Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.
1/2016	Genetic Associations With White Matter Hyperintensities Confer Risk of Lacunar Stroke.
10/2015	Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study.
7/2015	Family History in Young Patients With Stroke.
10/2014	Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.
11/2013	Population-based case-control study of white matter changes on brain imaging in transient ischemic attack and ischemic stroke.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter M Rothwell Research Topics

Disease

131	Stroke (Strokes) 12/2022 - 01/2003
59	Ischemic Stroke 01/2022 - 10/2004
27	Transient Ischemic Attack 01/2022 - 10/2004
26	Carotid Stenosis (Carotid Artery Stenosis) 12/2022 - 07/2003
18	Pathologic Constriction (Stenosis) 12/2022 - 01/2004
14	Neoplasms (Cancer) 01/2018 - 10/2004
13	Hemorrhage 01/2021 - 09/2009
12	Hypertension (High Blood Pressure) 01/2022 - 04/2005
10	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 05/2007
9	Myocardial Infarction 05/2020 - 07/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2012
6	Atherosclerosis 01/2021 - 10/2010
6	Inflammation (Inflammations) 01/2021 - 10/2010
5	Thrombosis (Thrombus) 01/2021 - 11/2010
5	Vascular Diseases (Vascular Disease) 09/2013 - 01/2008
4	Cerebral Hemorrhage 10/2021 - 10/2006
4	Embolic Stroke 03/2019 - 12/2012
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2018 - 09/2015
4	Atrial Fibrillation 01/2017 - 09/2010
3	Lacunar Stroke 01/2021 - 01/2016
3	Dementia (Dementias) 06/2020 - 11/2009
3	Diabetes Mellitus 01/2020 - 10/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2019 - 08/2012
3	Peripheral Arterial Disease 01/2019 - 09/2010
3	Leukoaraiosis 11/2014 - 09/2012
3	Neoplasm Metastasis (Metastasis) 07/2014 - 04/2012
3	Adenoma (Adenomas) 01/2013 - 05/2007
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2013
2	Leukoencephalopathies 01/2020 - 07/2015
2	Cerebral Small Vessel Diseases 10/2018 - 03/2015
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 05/2014
2	Cognitive Dysfunction 11/2016 - 11/2014
2	Migraine Disorders (Migraine) 10/2015 - 01/2013
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 07/2014 - 02/2012
2	Acute Coronary Syndrome 10/2013 - 05/2010
2	Venous Thromboembolism 09/2013 - 08/2012
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2012 - 01/2011
2	Infarction (Infarctions) 12/2009 - 05/2008
2	Coronary Disease (Coronary Heart Disease) 01/2009 - 10/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Chronic Disease (Chronic Diseases) 10/2021

Drug/Important Bio-Agent (IBA)

26	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 10/2004
13	danaparoid (Orgaran)FDA Link 01/2020 - 03/2011
12	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 03/2010
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021 - 11/2011
5	terutrobanIBA 03/2019 - 11/2011
5	LipidsIBA 01/2019 - 01/2005
5	Pharmaceutical PreparationsIBA 01/2018 - 03/2010
4	AnticoagulantsIBA 01/2021 - 09/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020 - 10/2013
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 05/2010
3	Amlodipine (Norvasc)FDA LinkGeneric 01/2020 - 05/2010
3	Angiotensin Receptor AntagonistsIBA 01/2020 - 09/2010
3	CholesterolIBA 01/2019 - 04/2005
3	ORALIT (ORS)IBA 01/2017 - 01/2004
3	CreatinineIBA 12/2015 - 11/2014
3	Fibrinogen (Factor I)FDA Link 09/2013 - 10/2004
2	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 12/2022 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
2	A-factor (Streptomyces)IBA 01/2022 - 10/2004
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 05/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	cyclo(Arg-Pro) (CI 4)IBA 10/2021 - 07/2002
2	Proton Pump InhibitorsIBA 01/2021 - 01/2016
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 01/2017
2	Calcium Channels (Calcium Channel)IBA 01/2020 - 01/2019
2	Valsartan (Vals)FDA Link 01/2020 - 01/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 01/2019
2	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2019 - 01/2019
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 03/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 02/2012
2	Clopidogrel (Plavix)FDA Link 01/2018 - 01/2016
2	Dipyridamole (Persantine)FDA LinkGeneric 01/2018 - 07/2016
2	omega-Chloroacetophenone (Mace)IBA 01/2017 - 04/2016
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 01/2005
2	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 03/2015
2	Atenolol (Tenormin)FDA LinkGeneric 12/2015 - 05/2010
2	AlbuminsIBA 12/2015 - 12/2014
2	CollagenIBA 03/2015 - 03/2010
2	C-Reactive ProteinIBA 10/2014 - 01/2005
2	DiureticsIBA 10/2014 - 05/2010
2	Lipoprotein(a)IBA 08/2012 - 01/2005
2	Retinaldehyde (Retinal)IBA 05/2008 - 09/2006
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Advanced Oxidation Protein Products (AOPP)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	semaglutideIBA 01/2022

Therapy/Procedure

33	Secondary Prevention 01/2022 - 01/2003
23	Therapeutics 01/2022 - 01/2005
21	Endarterectomy (Thromboendarterectomy) 01/2021 - 01/2004
18	Carotid Endarterectomy 01/2017 - 07/2003
7	Length of Stay 04/2015 - 10/2006
3	Institutionalization (Institutionalized Persons) 06/2020 - 10/2013
3	Stents 08/2019 - 07/2009
2	Contraindications 11/2015 - 06/2010
2	Chemoprevention 01/2013 - 02/2012
2	Emergency Treatment 12/2007 - 03/2005